- The trend backdrop is active with a 2-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
NANEXA
STO
Week ended 07 Aug 2026
Weekly Investor Report
Nanexa AB (publ) · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
4.16 SEK
-2.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 8.9% above the Trend Line and sits at 76.7% of its 52-week range. The latest completed week returned -2.9%, after a 12.4% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
55
out of 100
Latest Close
4.16 SEK
7 Aug 2026
1W Return
-2.9%
latest completed week
4W Return
12.4%
short-term follow-through
12W Return
12.9%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- 4 reversal markers appear in the recent smart-money tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.9%
Latest completed week; four-week move 12.4%.
Indicator stack
50/47
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 8.9% above the Trend Line and sits at 76.7% of its 52-week range. The latest completed week returned -2.9%, after a 12.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6712-week average 0.64
12-week confirmation
Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.67Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.4% over four weeks, 12.9% over 12 weeks, and 82.9% over one year. The current trend has remained active for 2 consecutive weeks.
Performance by holding period
Active trend streak2 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.38Latest activity-pressure read.
Pressure change43.4%Four-week change in activity pressure.
Leadership16.22Latest relative-leadership reading.
RS change52.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.8%Distance below the 52-week high.
13-week volatility8.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+18.4%Week of 29 May.
Worst week-12.4%Week of 19 Jun.
Latest week-2.9%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains5
Flat weeks0
Modest losses10
Sharp losses4
Recent vol8.1%13-week weekly-return volatility.
Base vol11.3%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew8.2% / -4.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSE Healthcare
4-week rank13 / 100
Group average-1.1%
Trend breadth39.0%
Trend39.0%active weekly trend signals
MD42.0%positive activity pressure
RS21.0%positive relative leadership
Four-week leaders
IndustrySE Drug Manufacturers - Specialty & Generic
4-week rank4 / 19
Group average1.8%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD36.8%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape51/100
Trend, activity pressure, participation, and risk combine to a 51/100 tape read.
Indicator analysis54/100Latest 12-week confirmation: trend 9/12, activity pressure 2/12, relative leadership 12/12.
Activity pressure 0.67; 4 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4.16 SEK | -2.9% | 3.82 SEK | 2.05 SEK | -0.38 | 16.22 | 1.1M | On |
| 31 Jul 2026 | 4.29 SEK | 16.8% | 3.82 SEK | 2.04 SEK | -0.60 | 22.96 | 1.8M | On |
| 24 Jul 2026 | 3.67 SEK | -0.5% | 3.81 SEK | 2.04 SEK | -0.94 | 7.85 | 869.6K | Off |
| 17 Jul 2026 | 3.69 SEK | -0.3% | 3.83 SEK | 2.04 SEK | -0.91 | 10.84 | 1.1M | Off |
| 10 Jul 2026 | 3.70 SEK | 4.2% | 3.82 SEK | 2.04 SEK | -0.67 | 10.67 | 1.9M | Off |
| 3 Jul 2026 | 3.55 SEK | -3.0% | 3.79 SEK | 2.04 SEK | -0.42 | 4.47 | 200.4K | On |
| 26 Jun 2026 | 3.66 SEK | -6.4% | 3.74 SEK | 2.04 SEK | -0.13 | 11.39 | 248.2K | On |
| 19 Jun 2026 | 3.91 SEK | -12.4% | 3.67 SEK | 2.04 SEK | 0.20 | 18.88 | 3.0M | On |
| 12 Jun 2026 | 4.46 SEK | 4.1% | 3.60 SEK | 2.03 SEK | 0.00 | 38.97 | 217.9K | On |
| 5 Jun 2026 | 4.29 SEK | 0.4% | 3.51 SEK | 2.03 SEK | -0.25 | 34.64 | 222.4K | On |
| 29 May 2026 | 4.28 SEK | 18.4% | 3.42 SEK | 2.02 SEK | -0.45 | 34.62 | 3.5M | On |
| 22 May 2026 | 3.61 SEK | -2.0% | 3.34 SEK | 2.02 SEK | -0.73 | 14.58 | 1.9M | On |
| 15 May 2026 | 3.69 SEK | 2.2% | 3.29 SEK | 2.01 SEK | -0.64 | 21.84 | 1.9M | On |
| 8 May 2026 | 3.60 SEK | 5.1% | 3.23 SEK | 2.01 SEK | -0.58 | 18.80 | 2.2M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.